Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BriBear who wrote (2259)	10/9/1997 10:32:00 PM
From: JOHN W.	of 6136

Due to the rather disappointing reaction to all the very positive events that this company has had, I have decided to return and fight another day. Welcome to the thread Bribear: I would like you to consider your concern of "HIV drug pipeline is picking up speed and older (relatively) drugs will get bumbed quickly in favor of newer ones." 1. I believe you are actually right, however the only second generation PI on the mkt for at least 2 years will be Viracept. As I was searching through the.street.com I found this article (10/3/97) on VRTX re VX-478 (not that I am confirming anything written in the.street.com): archive.thestreet.com I was not aware of the VX-478 dosing regimen, 16 pills a day. Fortovase (soft gel saq) requires , I believe 18 pills a day. Rit refrigeration requirements and taste make it equally non user-friendly. While BID Crixivan and BID Viracept prepare to enter the mkt (I don't have an estimate of the timeframe). 80 by Nov P.S. I have an uncanny misfortune of buying this stock at it's peaks too. Bought more at 56. moan.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next